Bende Richard J, Smit Laura A, Bossenbroek Janneke G, Aarts Wilhelmina M, Spaargaren Marcel, de Leval Laurence, Boeckxstaens Guy E E, Pals Steven T, van Noesel Carel J M
Department of Pathology, Academic Medical Center, Amsterdam, The Netherlands.
Am J Pathol. 2003 Jan;162(1):105-13. doi: 10.1016/s0002-9440(10)63802-3.
Primary follicular lymphoma of the gastrointestinal tract (GI-FL) is a rare so far poorly studied entity. We analyzed four FL cases located in the small intestine and duodenum to gain insight in their pathogenesis and to find an explanation for their low tendency to disseminate outside the GI tract. GI-FLs resemble nodal FLs with respect to morphology and expression of typical GC markers such as CD10, CD38, and BCL-6. We established that the high levels of the anti-apoptosis protein BCL-2 in the tumor cells are in all cases due to a t(14;18) involving the immunoglobulin heavy chain and BCL-2 loci. Detailed immunoglobulin gene analyses on microdissected tissue samples further supported the GC-cell derivation: GI-FLs carry extensively mutated variable heavy-chain genes. The mutation patterns indicated that at some time point in development stringent antigen receptor-based selection processes must have occurred. Interestingly, three of four neoplasms expressed surface IgA, an immunoglobulin class typical of the mucosal immune system and seldom found in nodal FL. In contrast to nodal FLs, the GI-FLs expressed the alpha4beta7 integrin, an established mucosa-homing receptor also expressed by normal intestinal B and T lymphocytes and by low-grade mucosa-associated lymphoid tissue lymphomas. However, the chemokine receptor CXCR3, expressed on low-grade mucosa-associated lymphoid tissue lymphomas, was not detected on the GI-FLs or on nodal FLs. The combined data suggests that primary FL of the small intestine is a distinct entity that originates from local antigen-responsive B cells.
原发性胃肠道滤泡性淋巴瘤(GI-FL)是一种罕见的疾病,迄今为止研究较少。我们分析了4例位于小肠和十二指肠的滤泡性淋巴瘤病例,以深入了解其发病机制,并解释其在胃肠道外扩散倾向较低的原因。GI-FL在形态学和典型生发中心(GC)标志物(如CD10、CD38和BCL-6)的表达方面与淋巴结滤泡性淋巴瘤相似。我们确定,肿瘤细胞中抗凋亡蛋白BCL-2的高水平在所有病例中均归因于涉及免疫球蛋白重链和BCL-2基因座的t(14;18)。对显微切割组织样本进行的详细免疫球蛋白基因分析进一步支持了其来源于GC细胞:GI-FL携带广泛突变的可变重链基因。突变模式表明,在发育的某个时间点必定发生了基于严格抗原受体的选择过程。有趣的是,4例肿瘤中有3例表达表面IgA,这是一种黏膜免疫系统特有的免疫球蛋白类别,在淋巴结滤泡性淋巴瘤中很少见。与淋巴结滤泡性淋巴瘤不同,GI-FL表达α4β7整合素,这是一种已确定的黏膜归巢受体,正常肠道B和T淋巴细胞以及低级黏膜相关淋巴组织淋巴瘤也表达该受体。然而,在GI-FL或淋巴结滤泡性淋巴瘤中未检测到低级黏膜相关淋巴组织淋巴瘤中表达的趋化因子受体CXCR3。综合数据表明,小肠原发性滤泡性淋巴瘤是一种独特的实体,起源于局部抗原反应性B细胞。